Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
about
Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritisTreatment for lupus nephritisTreatment for lupus nephritisRisk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.Management of therapy-resistant systemic lupus erythematosus with rituximab: report of a case and review of the literature.Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Treatment Results of Patients With Lupus Nephritis: A Single Center's ExperienceRandomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.Lupus nephritis: an overview of recent findings.Lupus nephritis: a review of the current pharmacological treatments.Challenges in bringing the bench to bedside in drug development for SLE.Emergence of targeted immune therapies for systemic lupus.Long-term post-marketing surveillance of mizoribine for the treatment of lupus nephritis: Safety and efficacy during a 3-year follow-upIndications for plasma exchange in systemic lupus erythematosus in 2005.Contemporary treatment of systemic lupus erythematosus: an update for clinicians.Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?Thirty years of cyclophosphamide: assessing the evidence.Current management of lupus nephritis: popular misconceptions.The Paediatric Rheumatology International Trials Organization (PRINTO).New treatment strategies for proliferative lupus nephritis: keep children in mind!Current treatment of lupus nephritis.Mycophenolate mofetil in the treatment of lupus nephritis.Beyond immunosuppression - challenges in the clinical management of lupus nephritis.Pharmacotherapy of systemic lupus erythematosus.Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions.Major lupus organ involvement: severe lupus nephritis.Treatment of proliferative lupus nephritis: a slowly changing landscape.Recent advances in the treatment of lupus nephritis.B-cell depletion in the treatment of lupus nephritis.Pediatric lupus nephritis: more options, more chances?A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients.Why we need guidelines for clinical trials in vasculitis and systemic lupus erythematosus.Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS).Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.First international meeting on mycophenolate mofetil: an advance in the treatment of lupus 27 April 2004, St Thomas' Hospital, London, UK.Concentration-controlled treatment of lupus nephritis with mycophenolate mofetil.Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis.Therapeutic potential of DCB-SLE1, an extract of a mixture of Chinese medicinal herbs, for severe lupus nephritis.
P2860
Q21195423-A7733EDE-A197-4715-9F21-519C87C479B5Q24202572-302D7B79-2E31-49B3-8C9B-07A23316C99FQ24247408-054DE00B-72A3-4504-AE1E-88E6191212E5Q30245390-62C38859-CFC9-4BF0-850A-063BF3E5979BQ33367691-995DBC25-7F1D-4E27-BB3F-223A8A647E1DQ34490782-8E397FB3-C951-4580-97C4-77A1E4F4BE86Q34665848-730D52B7-D1E5-4178-A7F5-0A357DBCB192Q35310520-A3E7B588-07AF-481C-8750-3C5D86177702Q35867038-4216E495-960C-48A6-9F24-020DB83C8659Q35925513-8BF91142-253A-4B1C-829D-0AD573539A6CQ35968394-015356B3-0DD6-4AF8-B4F0-2217508C4CE8Q36066014-855CAB97-002C-4DDD-ACC3-537ACD535EBCQ36165790-15F09DA7-CD5A-4F71-B863-D57432C36092Q36334472-B8E70905-4C6A-4AEF-9D9E-861D191DFBB2Q36443689-C9C586C9-8863-4398-B9B4-6CB53B93FF20Q36577362-AC1AF9D8-E6DB-4CBC-98CD-ED7392D189A5Q36790803-78A2564F-90A1-4A88-8B4E-8D4DA38C3F5BQ36790809-E709B98D-3A57-4708-AE5C-B764D2C0160CQ36915684-59C6FBA9-F0E3-4204-A715-98D809664889Q36915693-F634E508-BF26-4CA0-9FCC-1D2D96B8C827Q37168027-83317AF7-6CCE-4552-9CA2-FB7BE76BE6B5Q37290624-E4E117EB-8086-436E-9300-D67F9402F3D4Q37371383-1AC56154-6AE7-4163-9925-81EEB3F2837BQ37510905-F8831FB7-74BE-444C-B267-7E8BB31F4E63Q37678723-F837A05A-A691-49FF-AE20-780385573A10Q37800295-0FB0B39E-1ACC-4B82-8780-3315B4EAD86FQ37822658-A67244FD-826A-4442-A7ED-691002EEE5EAQ37953243-0F753D32-682A-4F0C-B2FC-B477B3470558Q38026784-CE4D9B01-34B3-4014-AF90-4C49859D99E6Q38102946-7BEE42D3-FE30-467F-B86A-41039BD30015Q38465496-E06520A9-9FB7-44EA-9137-8EA4DA59AB89Q42160904-08381E03-9D2C-4160-A58D-05DFBFEE30C7Q42638034-B4ABF281-43B2-443B-BF97-EC8987BA37DCQ43004356-E455D0D7-AB4D-4818-A633-C671265E5A37Q43031095-3A9288D8-1F1E-4D9E-9E4E-7E210326128BQ45047982-29DA33A2-6D70-4425-98E5-616A7D89CFA2Q45353017-6D51D761-2129-412F-9C10-EA3B07DAA3FBQ46484874-167ADD79-0C72-4E96-86AF-24330CDA48B3Q50036922-752BEDC0-09E2-4459-8FD2-40D2DA4EA1CCQ50041410-CA5CB94C-42D4-4146-A8E8-3A10FF6D1AFE
P2860
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Treatment of diffuse prolifera ...... randomized controlled trials.
@ast
Treatment of diffuse prolifera ...... randomized controlled trials.
@en
type
label
Treatment of diffuse prolifera ...... randomized controlled trials.
@ast
Treatment of diffuse prolifera ...... randomized controlled trials.
@en
prefLabel
Treatment of diffuse prolifera ...... randomized controlled trials.
@ast
Treatment of diffuse prolifera ...... randomized controlled trials.
@en
P2093
P1476
Treatment of diffuse prolifera ...... randomized controlled trials.
@en
P2093
Giovanni F M Strippoli
Matthew A Roberts
Peter G Kerr
Robert C Atkins
Robert S Flanc
Steven J Chadban
P304
P356
10.1053/J.AJKD.2003.10.012
P577
2004-02-01T00:00:00Z